{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:14:13Z","timestamp":1781075653518,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,11]]},"DOI":"10.7759\/cureus.55975","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T22:56:36Z","timestamp":1710197796000},"source":"Crossref","is-referenced-by-count":6,"title":["Pain Management in Multiple Myeloma Patients: A Literature Review"],"prefix":"10.7759","author":[{"given":"Shubh","family":"Rana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suprina","family":"Maharjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanisha D","family":"Sookdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21453","article-title":"Optimal pain management for patients with cancer in the modern era","volume":"68","author":"Scarborough BM","year":"2018","unstructured":"Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin. 2018, 68:182-96. 10.3322\/caac.21453","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0885-3924(02)00411-6","article-title":"The impact of pain management on quality of life","volume":"24","author":"Katz N","year":"2002","unstructured":"Katz N. The impact of pain management on quality of life. J Pain Symptom Manage. 2002, 24:38-47. 10.1016\/s0885-3924(02)00411-6","journal-title":"J Pain Symptom Manage"},{"key":"ref3","article-title":"Multiple myeloma","author":"Albagoush SA","year":"2023","unstructured":"Albagoush SA, Shumway C, Azevedo AM. Multiple myeloma. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2013.04.001","article-title":"Myeloma bone disease: pathophysiology and management","volume":"2","author":"Silbermann R","year":"2013","unstructured":"Silbermann R, Roodman GD. Myeloma bone disease: pathophysiology and management. J Bone Oncol. 2013, 2:59-69. 10.1016\/j.jbo.2013.04.001","journal-title":"J Bone Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4137\/CGM.S16817","article-title":"Bone disease in multiple myeloma: pathophysiology and management","volume":"7","author":"Hameed A","year":"2014","unstructured":"Hameed A, Brady JJ, Dowling P, Clynes M, O'Gorman P. Bone disease in multiple myeloma: pathophysiology and management. Cancer Growth Metastasis. 2014, 7:33-42. 10.4137\/CGM.S16817","journal-title":"Cancer Growth Metastasis"},{"key":"ref6","unstructured":"Multiple Myeloma. (2023). Accessed. October 24, 2023: https:\/\/emedicine.medscape.com\/article\/204369-overview?form=fpf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1429","article-title":"Patient-reported pain severity and health-related quality of life in patients with multiple myeloma in real world clinical practice","volume":"5","author":"Ludwig H","year":"2022","unstructured":"Ludwig H, Bailey AL, Marongiu A, et al.. Patient-reported pain severity and health-related quality of life in patients with multiple myeloma in real world clinical practice. Cancer Rep (Hoboken). 2022, 5:1429. 10.1002\/cnr2.1429","journal-title":"Cancer Rep (Hoboken)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-022-06979-7","article-title":"Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed\/refractory multiple myeloma","volume":"30","author":"Nathwani N","year":"2022","unstructured":"Nathwani N, Bell J, Cherepanov D, Sowell FG, Shah R, McCarrier K, Hari P. Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed\/refractory multiple myeloma. Support Care Cancer. 2022, 30:5859-69. 10.1007\/s00520-022-06979-7","journal-title":"Support Care Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2022.1015497","article-title":"Pain as a risk factor of depression and anxiety symptoms with multiple myeloma during maintenance therapy","volume":"13","author":"Shi H","year":"2022","unstructured":"Shi H, Ren H, Tian Y, et al.. Pain as a risk factor of depression and anxiety symptoms with multiple myeloma during maintenance therapy. Front Psychol. 2022, 13:1015497. 10.3389\/fpsyg.2022.1015497","journal-title":"Front Psychol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07759-7","article-title":"The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis","volume":"31","author":"Zeng L","year":"2023","unstructured":"Zeng L, Huang H, Liu Y, Ruan C, Fan S, Xia Y, Zhou J. The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis. Support Care Cancer. 2023, 31:297. 10.1007\/s00520-023-07759-7","journal-title":"Support Care Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.e24137","article-title":"Use of myeloma patient outcome Scale (MyPos) to gauge the effectiveness of palliative management in patients with multiple myeloma: experience from a large tertiary academic center in India","volume":"41","author":"Kapoor AK","year":"2023","unstructured":"Kapoor AK, Mishra S, Bhatnagar S, et al.. Use of myeloma patient outcome Scale (MyPos) to gauge the effectiveness of palliative management in patients with multiple myeloma: experience from a large tertiary academic center in India. J Clin Oncol. 2023, 41:24137. 10.1200\/JCO.2023.41.16_suppl.e24137","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.06.010","article-title":"Development of the multiple myeloma symptom and impact questionnaire: a new patient-reported outcome instrument to assess symptom and impacts in patients with multiple myeloma","volume":"24","author":"Gries KS","year":"2021","unstructured":"Gries KS, Fastenau J, Seo C, Potrata B, Iaconangelo C, Serrano D. Development of the multiple myeloma symptom and impact questionnaire: a new patient-reported outcome instrument to assess symptom and impacts in patients with multiple myeloma. Value Health. 2021, 24:1807-19. 10.1016\/j.jval.2021.06.010","journal-title":"Value Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.11.003","article-title":"Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life","volume":"46","author":"Boland E","year":"2013","unstructured":"Boland E, Eiser C, Ezaydi Y, Greenfield DM, Ahmedzai SH, Snowden JA. Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. J Pain Symptom Manage. 2013, 46:671-80. 10.1016\/j.jpainsymman.2012.11.003","journal-title":"J Pain Symptom Manage"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.612696","article-title":"Approaches and challenges in the management of multiple myeloma in the very old: future treatment prospects","volume":"8","author":"Kaweme NM","year":"2021","unstructured":"Kaweme NM, Changwe GJ, Zhou F. Approaches and challenges in the management of multiple myeloma in the very old: future treatment prospects. Front Med (Lausanne). 2021, 8:612696. 10.3389\/fmed.2021.612696","journal-title":"Front Med (Lausanne)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07902-4","article-title":"Assessment tools for patient-reported outcomes in multiple myeloma","volume":"31","author":"Wang T","year":"2023","unstructured":"Wang T, Lu Q, Tang L. Assessment tools for patient-reported outcomes in multiple myeloma. Support Care Cancer. 2023, 31:431. 10.1007\/s00520-023-07902-4","journal-title":"Support Care Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00543-y","article-title":"Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvement","volume":"11","author":"Fernandes LL","year":"2021","unstructured":"Fernandes LL, Zhou J, Kanapuru B, Horodniceanu E, Gwise T, Kluetz PG, Bhatnagar V. Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvement. Blood Cancer J. 2021, 11:148. 10.1038\/s41408-021-00543-y","journal-title":"Blood Cancer J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-128220","article-title":"Health-related quality of life in patients with relapsed\/refractory multiple myeloma treated with isatuximab plus pomalidomide and dexamethasone: Icaria-MM study","volume":"134","author":"Houghton K","year":"2019","unstructured":"Houghton K, Dimopoulos M, Lin P, et al.. Health-related quality of life in patients with relapsed\/refractory multiple myeloma treated with isatuximab plus pomalidomide and dexamethasone: Icaria-MM study. Blood. 2019, 134:1850. 10.1182\/blood-2019-128220","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11122037","article-title":"Pain management in patients with multiple myeloma: an update","volume":"11","author":"Coluzzi F","year":"2019","unstructured":"Coluzzi F, Rolke R, Mercadante S. Pain management in patients with multiple myeloma: an update. Cancers (Basel). 2019, 11:2037. 10.3390\/cancers11122037","journal-title":"Cancers (Basel)"},{"key":"ref19","article-title":"Current aproach to cancer pain management: availability and implications of different treatment options","volume":"3","author":"Nersesyan H","year":"2007","unstructured":"Nersesyan H, Slavin KV. Current aproach to cancer pain management: availability and implications of different treatment options. Ther Clin Risk Manag. 2007, 3:381-400.","journal-title":"Ther Clin Risk Manag"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1178224219868235","article-title":"Multiple myeloma: an overview of management","volume":"13","author":"Bird SA","year":"2019","unstructured":"Bird SA, Boyd K. Multiple myeloma: an overview of management. Palliat Care Soc Pract. 2019, 13:1178224219868235. 10.1177\/1178224219868235","journal-title":"Palliat Care Soc Pract"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00432-4","article-title":"Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life","volume":"11","author":"Terpos E","year":"2021","unstructured":"Terpos E, Mikhael J, Hajek R, et al.. Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood Cancer J. 2021, 11:40. 10.1038\/s41408-021-00432-4","journal-title":"Blood Cancer J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00244","article-title":"Current treatment strategies for multiple myeloma","volume":"16","author":"Branagan A","year":"2020","unstructured":"Branagan A, Lei M, Lou U, Raje N. Current treatment strategies for multiple myeloma. JCO Oncol Pract. 2020, 16:5-14. 10.1200\/JOP.19.00244","journal-title":"JCO Oncol Pract"},{"key":"ref23","article-title":"Cancer pain (PDQ\u00ae): health professional version","year":"2022","unstructured":"Cancer pain (PDQ\u00ae). health professional version. PDQ Cancer Information Summaries [Internet]. National Cancer Institute (US), Bethesda (MD); 2022."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO clinical practice guidelines","volume":"29","author":"Fallon M","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI. Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann Oncol. 2018, 29:166-91. 10.1093\/annonc\/mdy152","journal-title":"Ann Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.185264","article-title":"Denosumab for bone lesions in multiple myeloma - what is its value?","volume":"103","author":"Goldstein DA","year":"2018","unstructured":"Goldstein DA. Denosumab for bone lesions in multiple myeloma - what is its value?. Haematologica. 2018, 103:753-4. 10.3324\/haematol.2017.185264","journal-title":"Haematologica"},{"key":"ref26","article-title":"A systematic review and meta-analysis of interventional studies of bisphosphonates and denosumab in multiple myeloma and future perspectives","volume":"22","author":"Chatziravdeli V","year":"2022","unstructured":"Chatziravdeli V, Katsaras GN, Katsaras D, Doxani C, Stefanidis I, Zintzaras E. A systematic review and meta-analysis of interventional studies of bisphosphonates and denosumab in multiple myeloma and future perspectives. J Musculoskelet Neuronal Interact. 2022, 22:596-621.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref27","unstructured":"Multiple Myeloma Pain. (2021). https.\/\/www.myeloma.org\/multiple-myeloma-pain."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2021.09.004","article-title":"Chemotherapy-induced peripheral neuropathy and rehabilitation: a review","volume":"48","author":"Zhang S","year":"2021","unstructured":"Zhang S. Chemotherapy-induced peripheral neuropathy and rehabilitation: a review. Semin Oncol. 2021, 48:193-207. 10.1053\/j.seminoncol.2021.09.004","journal-title":"Semin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-021-00168-y","article-title":"Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment","volume":"9","author":"Burgess J","year":"2021","unstructured":"Burgess J, Ferdousi M, Gosal D, et al.. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment. Oncol Ther. 2021, 9:385-450. 10.1007\/s40487-021-00168-y","journal-title":"Oncol Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179257","article-title":"Integrated medicine for chemotherapy-induced peripheral neuropathy","volume":"22","author":"Tsai CH","year":"2021","unstructured":"Tsai CH, Lin YH, Li YS, Ho TL, Hoai Thuong LH, Liu YH. Integrated medicine for chemotherapy-induced peripheral neuropathy. Int J Mol Sci. 2021, 22:9257. 10.3390\/ijms22179257","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00560-x","article-title":"Lifestyle considerations in multiple myeloma","volume":"11","author":"Shapiro YN","year":"2021","unstructured":"Shapiro YN, Peppercorn JM, Yee AJ, Branagan AR, Raje NS, Donnell EK. Lifestyle considerations in multiple myeloma. Blood Cancer J. 2021, 11:172. 10.1038\/s41408-021-00560-x","journal-title":"Blood Cancer J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21639","article-title":"A systematic review of rehabilitation and exercise recommendations in oncology guidelines","volume":"71","author":"Stout NL","year":"2021","unstructured":"Stout NL, Santa Mina D, Lyons KD, Robb K, Silver JK. A systematic review of rehabilitation and exercise recommendations in oncology guidelines. CA Cancer J Clin. 2021, 71:149-75. 10.3322\/caac.21639","journal-title":"CA Cancer J Clin"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100476","article-title":"Supportive care in multiple myeloma: current practices and advances","volume":"29","author":"Miceli TS","year":"2021","unstructured":"Miceli TS, Gonsalves WI, Buadi FK. Supportive care in multiple myeloma: current practices and advances. Cancer Treat Res Commun. 2021, 29:100476. 10.1016\/j.ctarc.2021.100476","journal-title":"Cancer Treat Res Commun"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2003.11.003","article-title":"Health-related quality of life and pain beliefs among people suffering from chronic pain","volume":"5","author":"Dysvik E","year":"2004","unstructured":"Dysvik E, Lindstr\u00f8m TC, Eikeland OJ, Natvig GK. Health-related quality of life and pain beliefs among people suffering from chronic pain. Pain Manag Nurs. 2004, 5:66-74. 10.1016\/j.pmn.2003.11.003","journal-title":"Pain Manag Nurs"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194978","article-title":"Management of adverse events and supportive therapy in relapsed\/refractory multiple myeloma","volume":"13","author":"Pozzi S","year":"2021","unstructured":"Pozzi S, Bari A, Pecherstorfer M, Vallet S. Management of adverse events and supportive therapy in relapsed\/refractory multiple myeloma. Cancers (Basel). 2021, 13:4978. 10.3390\/cancers13194978","journal-title":"Cancers (Basel)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0040-1","article-title":"Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network","volume":"32","author":"Ludwig H","year":"2018","unstructured":"Ludwig H, Delforge M, Facon T, et al.. Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network. Leukemia. 2018, 32:1542-60. 10.1038\/s41375-018-0040-1","journal-title":"Leukemia"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1586\/era.10.5","article-title":"Pain management in multiple myeloma","volume":"10","author":"Niscola P","year":"2010","unstructured":"Niscola P, Scaramucci L, Romani C, et al.. Pain management in multiple myeloma. Expert Rev Anticancer Ther. 2010, 10:415-25. 10.1586\/era.10.5","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.2016.004663","article-title":"Assessment of adequacy of pain management and analgesic use in patients with advanced cancer using the Brief Pain Inventory and pain management index calculation","volume":"3","author":"Singh H","year":"2017","unstructured":"Singh H, Banipal RP, Singh B. Assessment of adequacy of pain management and analgesic use in patients with advanced cancer using the Brief Pain Inventory and pain management index calculation. J Glob Oncol. 2017, 3:235-41. 10.1200\/JGO.2016.004663","journal-title":"J Glob Oncol"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/8.suppl_3.S21","article-title":"Current strategies for pain control","volume":"8","author":"Ahmedzai S","year":"1997","unstructured":"Ahmedzai S. Current strategies for pain control. Ann Oncol. 1997, 8:21-4.","journal-title":"Ann Oncol"},{"key":"ref40","article-title":"Management of pain: understanding the current needs of patients with multiple myeloma","author":"Bhurke S","year":"2022","unstructured":"Bhurke S. Management of pain: understanding the current needs of patients with multiple myeloma. Multiple Myeloma Hub. 2022,","journal-title":"Multiple Myeloma Hub"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/tbm\/ibac099","article-title":"Survey of patients and physicians on shared decision-making in treatment selection in relapsed\/refractory multiple myeloma","volume":"13","author":"Bylund CL","year":"2023","unstructured":"Bylund CL, Eggly S, LeBlanc TW, et al.. Survey of patients and physicians on shared decision-making in treatment selection in relapsed\/refractory multiple myeloma. Transl Behav Med. 2023, 13:255-67. 10.1093\/tbm\/ibac099","journal-title":"Transl Behav Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1188\/20.CJON.538-546","article-title":"Characterizing pain experiences: African American patients with multiple myeloma taking around-the-clock opioids","volume":"24","author":"Belcher SM","year":"2020","unstructured":"Belcher SM, Watkins Bruner D, Hofmeister CC, Kweon J, Meghani SH, Yeager KA. Characterizing pain experiences: African American patients with multiple myeloma taking around-the-clock opioids. Clin J Oncol Nurs. 2020, 24:538-46. 10.1188\/20.CJON.538-546","journal-title":"Clin J Oncol Nurs"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174082","article-title":"Multiple myeloma therapy: Emerging trends and challenges","volume":"14","author":"Dima D","year":"2022","unstructured":"Dima D, Jiang D, Singh DJ, et al.. Multiple myeloma therapy: Emerging trends and challenges. Cancers (Basel). 2022, 14:4082. 10.3390\/cancers14174082","journal-title":"Cancers (Basel)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgad025","article-title":"Data gaps and opportunities for modeling cancer health equity","volume":"2023","author":"Trentham-Dietz A","year":"2023","unstructured":"Trentham-Dietz A, Corley DA, Del Vecchio NJ, et al.. Data gaps and opportunities for modeling cancer health equity. J Natl Cancer Inst Monogr. 2023, 2023:246-54. 10.1093\/jncimonographs\/lgad025","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1080\/23808993.2020.1732205","article-title":"Proteomics-inspired precision medicine for treating and understanding multiple myeloma","volume":"5","author":"Ho M","year":"2020","unstructured":"Ho M, Bianchi G, Anderson KC. Proteomics-inspired precision medicine for treating and understanding multiple myeloma. Expert Rev Precis Med Drug Dev. 2020, 5:67-85. 10.1080\/23808993.2020.1732205","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"ref46","unstructured":"Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF). (2020). https.\/\/www.cms.gov\/medicare-coverage-database\/view\/lcd.aspx?lcdid=35130."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/233819-pain-management-in-multiple-myeloma-patients-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T22:56:41Z","timestamp":1710197801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/233819-pain-management-in-multiple-myeloma-patients-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.55975","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,11]]}}}